Hepatitis A: Epidemiology in resource-poor countries

Current Opinion in Infectious Diseases

Volumn 28, Issue 5, 2015, Pages 488-496

  Aggarwal, Rakesh ^a   Goel, Amit ^a  

^a SANJAY GANDHI POSTGRADUATE INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

hepatitis A; morbidity; mortality; seroepidemiology; vaccination

Indexed keywords

ANTIBODY RESPONSE; ENDEMIC DISEASE; GENETIC EPIDEMIOLOGY; GENETIC HETEROGENEITY; HEPATITIS A; HEPATITIS A VIRUS; HUMAN; IMMUNOPROPHYLAXIS; NONHUMAN; REVIEW; VACCINATION; VIRAL CONTAMINATION; VIRION; VIRUS GENOME; VIRUS MORPHOLOGY; VIRUS PATHOGENESIS; VIRUS TRANSMISSION; COST BENEFIT ANALYSIS; DEVELOPING COUNTRY; ECONOMICS; MORTALITY; PREVENTIVE HEALTH SERVICE;

HEPATITIS A VACCINE;

COST-BENEFIT ANALYSIS; DEVELOPING COUNTRIES; HEPATITIS A; HEPATITIS A VACCINES; HUMANS; IMMUNIZATION PROGRAMS;

EID: 84958699044     PISSN: 09517375     EISSN: 14736527     Source Type: Journal    
DOI: 10.1097/QCO.0000000000000188     Document Type: Review

References (62)

1. WHO position paper on hepatitis A vaccines - June 2012. Wkly Epidemiol Rec. 2012; 87: 261-276.
2. Vaughan G, Goncalves Rossi LM, Forbi JC, et al. Hepatitis A virus: host interactions, molecular epidemiology and evolution. Infect Genet Evol. 2014; 21: 227-243.
3. Feng Z, Hensley L, McKnight KL, et al. A pathogenic picornavirus acquires an envelope by hijacking cellular membranes. Nature. 2013; 496: 367-371.
4. Feng Z, Lemon SM. Peek-A-boo: membrane hijacking and the pathogenesis of viral hepatitis. Trends Microbiol. 2014; 22: 59-64.
5. Siegl G, WeitzM, Kronauer G. Stability of hepatitis A virus. Intervirology. 1984; 22: 218-226.
6. Scholz E, Heinricy U, Flehmig B. Acid stability of hepatitis A virus. J Gen Virol. 1989; 70 (Pt 9): 2481-2485.
7. Sun Y, Laird DT, Shieh YC. Temperature-dependent survival of hepatitis A virus during storage of contaminated onions. Appl Environ Microbiol. 2012; 78: 4976-4983.
8. Bae S-C, Park SY, Kim A-N, et al. Survival of hepatitis A virus on various foodcontact surfaces during 28 days of storage at room temperature. Food Res Int. 2014; 64: 849-854.
9. WangQ, Erickson MC, Ortega Y, Cannon JL. Physical removal and transfer of murine norovirus and hepatitis A virus from contaminated produce by scrubbing and peeling. J Food Prot. 2013; 76: 85-92.
10. Robertson BH, Jansen RW, Khanna B, et al. Genetic relatedness of hepatitis A virus strains recovered from different geographical regions. J Gen Virol. 1992; 73 (Pt 6): 1365-1377.
11. Costa-Mattioli M, Cristina J, Romero H, et al. Molecular evolution of hepatitis A virus: a new classification based on the complete VP1 protein. J Virol. 2002; 76: 9516-9525.
12. Lee H, Jeong H, Yun H, et al. Genetic analysis of hepatitis A virus strains that induced epidemics in Korea during 2007-2009. J Clin Microbiol. 2012; 50: 1252-1257.
13. Kim JH, Yeon JE, Baik SK, et al. Genotypic shift of the hepatitis A virus and its clinical impact on acute hepatitis A in Korea: a nationwide multicenter study. Scand J Infect Dis. 2013; 45: 811-818.
14. Yun H, Lee HJ, Jang JH, et al. Hepatitis A virus genotype and its correlation with the clinical outcome of acute hepatitis A in Korea: 2006-2008. J Med Virol. 2011; 83: 2073-2081.
15. Singh MP, Majumdar M, Thapa BR, et al. Molecular characterization of hepatitis A virus strains in a tertiary care health set up in north western India. Indian J Med Res. 2015; 141: 213-220.
16. Bose M, Bose S, Saikia A, et al. Molecular epidemiology of hepatitis A virus infection in Northeast India. J Med Virol. 2015; 87: 1218-1224.
17. Barde PV, Shukla MK, Pathak R, et al. Circulation of hepatitis A genotype IIIA virus in paediatric patients in central India. Indian J Med Res. 2014; 139: 940-944.
18. Vaughan G, Xia G, Forbi JC, et al. Genetic relatedness among hepatitis A virus strains associated with food-borne outbreaks. PLoS One. 2013; 8: e74546.
19. Gallot C, Grout L, Roque-Afonso AM, et al. Hepatitis A associated with semidried tomatoes, France, 2010. Emerg Infect Dis. 2011; 17: 566-567.
20. Petrignani M, Harms M, Verhoef L, et al. Update: a food-borne outbreak of hepatitis A in the Netherlands related to semi-dried tomatoes in oil, January-February 2010. Euro Surveill. 2010; 15: pii: 19512.
21. Collier MG, Khudyakov YE, Selvage D, et al. Outbreak of hepatitis A in the USA associated with frozen pomegranate arils imported from Turkey: an epidemiological case study. Lancet Infect Dis. 2014; 14: 976-981.
22. Stapleton JT, Lemon SM. Neutralization escape mutants define a dominant immunogenic neutralization site on hepatitis A virus. J Virol. 1987; 61: 491-498.
23. Feigelstock D, Thompson P, Mattoo P, et al. The human homolog of HAVcr-1 codes for a hepatitis A virus cellular receptor. J Virol. 1998; 72: 6621-6628.
24. Kim HY, Eyheramonho MB, Pichavant M, et al. A polymorphism in TIM1 is associated with susceptibility to severe hepatitis A virus infection in humans. J Clin Invest. 2011; 121: 1111-1118.
25. Rubicz R, Leach CT, Kraig E, et al. Genetic factors influence serological measures of common infections. Hum Hered. 2011; 72: 133-141.
26. TjonGM, Coutinho RA, van den Hoek A, et al. High and persistent excretion of hepatitis A virus in immunocompetent patients. J Med Virol. 2006; 78: 1398-1405.
27. Bialek SR, George PA, Xia GL, et al. Use of molecular epidemiology to confirm a multistate outbreak of hepatitis A caused by consumption of oysters. Clin Infect Dis. 2007; 44: 838-840.
28. Halliday ML, Kang LY, Zhou TK, et al. An epidemic of hepatitis A attributable to the ingestion of raw clams in Shanghai, China. J Infect Dis. 1991; 164: 852-859.
29. Sjogren MH, Tanno H, Fay O, et al. Hepatitis A virus in stool during clinical relapse. Ann Intern Med. 1987; 106: 221-226.
30. de la Rubia L, del Pozo F, Carrasco M, et al. Persistence of anti-HAV IgM antibodies and relapse of hepatitis type A in childhood. J Hepatol. 1993; 17: 421-422.
31. Armstrong GL, Bell BP. Hepatitis A virus infections in the United States: model-based estimates and implications for childhood immunization. Pediatrics. 2002; 109: 839-845.
32. Mohd Hanafiah K, Jacobsen KH, Wiersma ST. Challenges to mapping the health risk of hepatitis A virus infection. Int J Health Geogr. 2011; 10: 57.
33. Jacobsen KH, Wiersma ST. Hepatitis A virus seroprevalence by age and world region, 1990 and 2005. Vaccine. 2010; 28: 6653-6657.
34. Ciocca M, Ramonet M, Cuarterolo M, et al. Prognostic factors in paediatric acute liver failure. Arch Dis Child. 2008; 93: 48-51.
35. Ciocca M, Moreira-Silva SF, Alegria S, et al. Hepatitis A as an etiologic agent of acute liver failure in Latin America. Pediatr Infect Dis J. 2007; 26: 711-715.
36. Santos DC,Martinho JM, Pacheco-Moreira LF, et al. Fulminant hepatitis failure in adults and children from a Public Hospital in Rio de Janeiro, Brazil. Braz J Infect Dis. 2009; 13: 323-329.
37. Kim YJ, Lee HS. Increasing incidence of hepatitis A in Korean adults. Intervirology. 2010; 53: 10-14.
38. Farajzadegan Z, Hoseini SG, Kelishadi R, et al. Systematic review and metaanalysis on the age-specific seroprevalence of hepatitis A in Iran. J Res Med Sci. 2014; 19: S56-63.
39. Melhem NM, Jaffa M, Zaatari M, et al. The changing pattern of hepatitis A in Lebanese adults. Int J Infect Dis. 2015; 30: 87-90.
40. Mayorga Perez O, Brinkhof MW, Egger M, et al. Decreasing risk of hepatitis A infection in Leon, Nicaragua: evidence from cross-sectional and longitudinal seroepidemiology studies. PLoS One. 2014; 9: e87643.
41. Melhem NM, Talhouk R, Rachidi H, Ramia S. Hepatitis A virus in the Middle East and North Africa region: a new challenge. J Viral Hepat. 2014; 21: 605-615.
42. Jacobsen KH. Hepatitis A virus in West Africa: Is an epidemiological transition beginning?. Niger Med J. 2014; 55: 279-284.
43. de Alencar Ximenes RA, Martelli CM, Merchan-Hamann E, et al. Multilevel analysis of hepatitis A infection in children and adolescents: a household survey in the Northeast and Central-west regions of Brazil. Int J Epidemiol. 2008; 37: 852-861.
44. Ximenes RA, Martelli CM, Amaku M, et al. Modelling the force of infection for hepatitis A in an urban population-based survey: a comparison of transmission patterns in Brazilian macro-regions. PLoS One. 2014; 9: e94622.
45. Mellou K, Sideroglou T, Papaevangelou V, et al. Considerations on the current universal vaccination policy against hepatitis A in Greece after recent outbreaks. PLoS One. 2015; 10: e0116939.
46. Arankalle VA, Sarada Devi KL, Lole KS, et al. Molecular characterization of hepatitis A virus from a large outbreak from Kerala, India. Indian J Med Res. 2006; 123: 760-769.
47. Rakesh P, Sherin D, Sankar H, et al. Investigating a community-wide outbreak of hepatitis a in India. J Glob Infect Dis. 2014; 6: 59-64.
48. Acharya SK, Batra Y, Bhatkal B, et al. Seroepidemiology of hepatitis A virus infection among school children in Delhi and north Indian patients with chronic liver disease: implications for HAV vaccination. J Gastroenterol Hepatol. 2003; 18: 822-827.
49. Victor JC, Monto AS, Surdina TY, et al. Hepatitis A vaccine versus immune globulin for postexposure prophylaxis. N Engl J Med. 2007; 357: 1685-1694.
50. Dagan R, Leventhal A, Anis E, et al. Incidence of hepatitis A in Israel following universal immunization of toddlers. JAMA. 2005; 294: 202-210.
51. Hanna JN, Hills SL, Humphreys JL. Impact of hepatitis A vaccination of Indigenous children on notifications of hepatitis A in north Queensland. Med J Aust. 2004; 181: 482-485.
52. Lopalco PL, Salleras L, Barbuti S, et al. Hepatitis A and B in children and adolescents - what can we learn from Puglia (Italy) and Catalonia (Spain)?. Vaccine. 2000; 19: 470-474.
53. Bovier PA, Bock J, Ebengo TF, et al. Predicted 30-year protection after vaccination with an aluminum-free virosomal hepatitis A vaccine. J Med Virol. 2010; 82: 1629-1634.
54. Lopez EL, Contrini MM, Mistchenko A, et al. Modeling the long-Term persistence of hepatitis a antibody after a two-dose vaccination schedule in argentinean children. Pediatr Infect Dis J. 2015; 34: 417-425.
55. Mayorga Perez O, Herzog C, Zellmeyer M, et al. Efficacy of virosome hepatitis A vaccine in young children in Nicaragua: randomized placebo-controlled trial. J Infect Dis. 2003; 188: 671-677.
56. Vacchino MN. Incidence of hepatitis A in Argentina after vaccination. J Viral Hepat. 2008; 15 (Suppl 2): 47-50.
57. Cervio G, Trentadue J, DAgostino D, et al. Decline in HAV-Associated fulminant hepatic failure and liver transplant in children in Argentina after the introduction of a universal hepatitis A vaccination program. Hepat Med. 2011; 3: 99-106.
58. Vizzotti C, Gonzalez J, Gentile A, et al. Impact of the single-dose immunization strategy against hepatitis A in Argentina. Pediatr Infect Dis J. 2014; 33: 84-88.
59. Vizzotti C, Pippo T, Uruena A, et al. Economic analysis of the single-dose immunization strategy against hepatitis A in Argentina. Vaccine. 2015; 33 (Suppl 1): A227-A232.
60. De Soarez PC, Sartori AM, Santos A, et al. Contributions from the systematic review of economic evaluations: the case of childhood hepatitis A vaccination in Brazil. Cad Saude Publica. 2012; 28: 211-228.
61. Sartori AM, de Soarez PC, Novaes HM, et al. Cost-effectiveness analysis of universal childhood hepatitis A vaccination in Brazil: regional analyses according to the endemic context. Vaccine. 2012; 30: 7489-7497.
62. Suwantika AA, Yegenoglu S, Riewpaiboon A, et al. Economic evaluations of hepatitis A vaccination in middle-income countries. Expert Rev Vaccines. 2013; 12: 1479-1494.